BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9329221)

  • 1. Antitumor activities of IL-12 and mechanisms of action.
    Shurin MR; Esche C; PĂ©ron JM; Lotze MT
    Chem Immunol; 1997; 68():153-74. PubMed ID: 9329221
    [No Abstract]   [Full Text] [Related]  

  • 2. Antitumor effects of interleukin-12 in pre-clinical and early clinical studies (Review).
    Golab J; Zagozdzon R
    Int J Mol Med; 1999 May; 3(5):537-44. PubMed ID: 10202188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of interleukin-12 (IL12) as an anti-tumour agent: experimental biology and clinical application.
    Zitvogel L; Lotze MT
    Res Immunol; 1995; 146(7-8):628-38. PubMed ID: 8839171
    [No Abstract]   [Full Text] [Related]  

  • 4. Interleukin-12: biological properties and clinical application.
    Del Vecchio M; Bajetta E; Canova S; Lotze MT; Wesa A; Parmiani G; Anichini A
    Clin Cancer Res; 2007 Aug; 13(16):4677-85. PubMed ID: 17699845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene therapy of cancer with interleukin-12.
    Mazzolini G; Prieto J; Melero I
    Curr Pharm Des; 2003; 9(24):1981-91. PubMed ID: 12871184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical use of systemic IL-12 therapy.
    Gollob JA; Mier JW; Atkins MB
    Cancer Chemother Biol Response Modif; 2001; 19():353-69. PubMed ID: 11686023
    [No Abstract]   [Full Text] [Related]  

  • 7. Antitumor effects of interleukin-12 (IL-12): applications for the immunotherapy and gene therapy of cancer.
    Tahara H; Lotze MT
    Gene Ther; 1995 Mar; 2(2):96-106. PubMed ID: 7719935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-12. Biologic activity, therapeutic utility, and role in disease.
    Hendrzak JA; Brunda MJ
    Lab Invest; 1995 Jun; 72(6):619-37. PubMed ID: 7783421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination nonviral interleukin 2 and interleukin 12 gene therapy for head and neck squamous cell carcinoma.
    Li D; Shugert E; Guo M; Bishop JS; O'Malley BW
    Arch Otolaryngol Head Neck Surg; 2001 Nov; 127(11):1319-24. PubMed ID: 11701067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-12 gene therapy using direct injection of tumors with genetically engineered autologous fibroblasts.
    Tahara H; Lotze MT; Robbins PD; Storkus WJ; Zitvogel L
    Hum Gene Ther; 1995 Dec; 6(12):1607-24. PubMed ID: 8664385
    [No Abstract]   [Full Text] [Related]  

  • 11. Interleukin-12: basic principles and clinical applications.
    Trinchieri G; Scott P
    Curr Top Microbiol Immunol; 1999; 238():57-78. PubMed ID: 10087650
    [No Abstract]   [Full Text] [Related]  

  • 12. The application of IL-12 to cytokine therapy and gene therapy for tumors.
    Nishimura T; Watanabe K; Yahata T; Uede T; Saiki I; Herrmann SH; Kobayashi M; Habu S
    Ann N Y Acad Sci; 1996 Oct; 795():375-8. PubMed ID: 8958959
    [No Abstract]   [Full Text] [Related]  

  • 13. Antitumor treatment using interleukin- 12-secreting marrow stromal cells in an invasive glioma model.
    Hong X; Miller C; Savant-Bhonsale S; Kalkanis SN
    Neurosurgery; 2009 Jun; 64(6):1139-46; discussion 1146-7. PubMed ID: 19487894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cloning and expression of the cDNA for canine interleukin-12.
    Okano F; Satoh M; Yamada K
    J Interferon Cytokine Res; 1997 Nov; 17(11):713-8. PubMed ID: 9402110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-targeted IL-2 amplifies T cell-mediated immune response induced by gene therapy with single-chain IL-12.
    Lode HN; Xiang R; Duncan SR; Theofilopoulos AN; Gillies SD; Reisfeld RA
    Proc Natl Acad Sci U S A; 1999 Jul; 96(15):8591-6. PubMed ID: 10411920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical review 131: Gene therapy for thyroid cancer: where do we stand?
    DeGroot LJ; Zhang R
    J Clin Endocrinol Metab; 2001 Jul; 86(7):2923-8. PubMed ID: 11443144
    [No Abstract]   [Full Text] [Related]  

  • 17. Differential antitumor effect of interleukin-12 family cytokines on orthotopic hepatocellular carcinoma.
    Lo CH; Chang CM; Tang SW; Pan WY; Fang CC; Chen Y; Wu PY; Chen KY; Ma HI; Xiao X; Tao MH
    J Gene Med; 2010 May; 12(5):423-34. PubMed ID: 20440753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The anti-tumor activity of IL-12: mechanisms of innate immunity that are model and dose dependent.
    Smyth MJ; Taniguchi M; Street SE
    J Immunol; 2000 Sep; 165(5):2665-70. PubMed ID: 10946296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor and antimetastatic activity of interleukin-12.
    Hendrzak JA; Brunda MJ
    Curr Top Microbiol Immunol; 1996; 213 ( Pt 3)():65-83. PubMed ID: 8815011
    [No Abstract]   [Full Text] [Related]  

  • 20. Cytokine gene therapy of cancer using interleukin-12: murine and clinical trials.
    Lotze MT; Zitvogel L; Campbell R; Robbins PD; Elder E; Haluszczak C; Martin D; Whiteside TL; Storkus WJ; Tahara H
    Ann N Y Acad Sci; 1996 Oct; 795():440-54. PubMed ID: 8958977
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.